Searched for
PSORIATIC ARTHRITIS
Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- Sun Pharma’s Ilumya expansion bid gets USFDA nod for reviewSun Pharmaceutical has received a significant approval from the USFDA. The company's innovative drug, Ilumya, is now being considered for t...
- Psoriatic Arthritis explained: Early signs, causes, and how to stop joint damage before it startsPsoriatic arthritis affects skin and joints with inflammation. This autoimmune condition causes pain, stiffness, and swelling. Early detect...
- Biocon Biologics launches product for autoimmune diseases in AustraliaBiocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating autoimmune di...
- Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global marketsLupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...
- Biocon Biologics secures multiple market access agreements in US for YesintekBiocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Mult...
- World Arthritis Day 2023: Types of arthritis, symptoms, treatment and self-care tipsWorld Arthritis Day observed on October 12 each year, aims to raise awareness of rheumatic and musculoskeletal diseases (RMDs). This year's...
- Aurobindo Pharma subsidiary enters pact with BioFactura for biosimilar ustekinumabCuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the US-based ...
- Shilpa Medicare gets tentative American health regulator nod for Apremilast tabletsThe company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast...
- World Autoimmune Arthritis Day: Don't let pain dominate your life. Early treatment, lifestyle changes are keyRheumatoid arthritis affects about 1 in 100 Indians.
- Sun Pharma erases gains to close in the redShares of Sun Pharma closed 0.45 per cent down at Rs 401 on BSE.
- Don't ignore joint pain with fever, fatigue: It can mean rheumatoid arthritisRheumatoid arthritis, an autoimmune disease, tends to affect women more than men.
- Reliance Life gains global rights for copies of InfliximabFor Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...
- Torrent Pharma launches Adalimumab biosimilar in IndiaThe company's product will be available as pre-filled syringe of 40 mg, Torrent Pharmaceuticals said in a statement.
- Zydus Cadila launches biosimilar of AbbVie's Humira in IndiaZydus Cadila today launched biosimilar of Adalimumab, used for treatment of auto immune disorders, at a price much lower than the innovator...
- Ranbaxy launches arthritis drug Infimab in IndiaInfimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...
- Cipla launches biosimilar for rheumatic disorders in IndiaDrug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...
- Strides Arcolab's arm Onco Therapies gets USFDA nod for cancer drug Methotrexate InjectionStrides Arcolab today said its subsidiary Onco Therapies received the US drug regulator's nod to sell cancer medicine Methotrexate Injectio...
- Now, a golden cure for arthritisInjecting gold into knees affected by osteoarthritis may ease pain and slow down the progress of the disease, but scientists say it does no...
Load More
